Liothyronine sodium and Hyperthyroidism aggravated - a phase IV clinical study of FDA data
Summary:
Hyperthyroidism aggravated is reported as a side effect among people who take Liothyronine sodium (liothyronine sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Cabozantinib, and have High blood pressure.
The phase IV clinical study analyzes which people have Hyperthyroidism aggravated when taking Liothyronine sodium. It is created by eHealthMe based on reports of 3,806 people who have side effects when taking Liothyronine sodium from the FDA, and is updated regularly.
What is Liothyronine sodium?
Liothyronine sodium has active ingredients of liothyronine sodium. It is often used in hypothyroidism. eHealthMe is studying from 4,276 Liothyronine sodium users. Check the latest studies of Liothyronine sodium.
What is Hyperthyroidism aggravated?
Hyperthyroidism aggravated (over activity of the thyroid gland) is found to be associated with 883 drugs and 362 conditions by eHealthMe. Check the latest studies of Hyperthyroidism aggravated.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
3,806 people reported to have side effects when taking Liothyronine sodium.
Among them, 27 people (0.71%) have Hyperthyroidism aggravated.

Among these 27 people:
How long have people been on Liothyronine sodium when they have Hyperthyroidism aggravated? *
- < 1 month: 33.33 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 33.33 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 33.33 %
- 10+ years: 0.0 %
What is the gender of people who have Hyperthyroidism aggravated when taking Liothyronine sodium? *
- female: 66.67 %
- male: 33.33 %
What is the age of people who have Hyperthyroidism aggravated when taking Liothyronine sodium? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 6.25 %
- 20-29: 31.25 %
- 30-39: 12.5 %
- 40-49: 12.5 %
- 50-59: 6.25 %
- 60+: 31.25 %
What are other drugs people take besides Liothyronine sodium? *
- Metformin: 3 people, 11.11%
- Dapagliflozin: 3 people, 11.11%
- Cabozantinib: 3 people, 11.11%
- Valsartan: 2 people, 7.41%
- Synthroid: 2 people, 7.41%
- Amlodipine: 2 people, 7.41%
- Vitamin D3: 1 person, 3.70%
- Tirosint: 1 person, 3.70%
- Pantoprazole: 1 person, 3.70%
- Oxycodone: 1 person, 3.70%
What are other side effects people have besides Hyperthyroidism aggravated? *
- Malaise (a feeling of general discomfort or uneasiness): 4 people, 14.81%
- Pancreatic Enzymes Increased: 3 people, 11.11%
- Hair Loss: 3 people, 11.11%
- Hepatic Enzyme Increased: 3 people, 11.11%
- Flank Pain (a distressing sensation experienced around the lower back and the upper abdomen): 3 people, 11.11%
- Fatigue (feeling of tiredness): 3 people, 11.11%
- Overdose: 3 people, 11.11%
- Respiratory Tract Infection: 3 people, 11.11%
- Sluggishness (lacking alertness): 2 people, 7.41%
- Hyperhidrosis (abnormally increased sweating): 2 people, 7.41%
What are the existing conditions these people have? *
- High Blood Pressure: 4 people, 14.81%
- Type 2 Diabetes: 3 people, 11.11%
- Renal Cell Carcinoma (a kidney cancer): 3 people, 11.11%
- Dyslipidaemia (abnormal amount of lipids): 3 people, 11.11%
- Weight Decreased: 2 people, 7.41%
- Vaginal Infection: 1 person, 3.70%
- Tri-Iodothyronine Decreased: 1 person, 3.70%
- Thyroxine Free Increased: 1 person, 3.70%
- Primary Hypothyroidism (failure of the thyroid gland to produce or release thyroid hormones into the bloodstream): 1 person, 3.70%
- Pain: 1 person, 3.70%
* Approximation only. Some reports may have incomplete information.
Do you take Liothyronine sodium and have Hyperthyroidism aggravated?
- Check whether Hyperthyroidism aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Liothyronine sodium:
- Liothyronine sodium (4,276 reports)
Hyperthyroidism aggravated treatments and more:
- Hyperthyroidism aggravated (29 reports)
How severe was Hyperthyroidism aggravated and when was it recovered:
Expand to all the drugs that have ingredients of liothyronine sodium:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Liothyronine sodium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hyperthyroidism aggravated:
- Hyperthyroidism aggravated (883 drugs)
Browse all the conditions that are associated with Hyperthyroidism aggravated:
- Hyperthyroidism aggravated (362 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on liothyronine sodium (the active ingredients of Liothyronine sodium) and Liothyronine sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ceftin cause Diverticulitis? - 4 seconds ago
- Could Dilaudid cause Upper Respiratory Tract Infection? - 8 seconds ago
- Could Aspirin cause Injection Site Dryness? - 13 seconds ago
- Could Actiq cause Chills? - 16 seconds ago
- Could Tramadol Hydrochloride cause Oxygen Saturation Decreased? - 18 seconds ago
- Drug interactions of Dimenhydrinate and Ondansetron - 19 seconds ago
- Could Lantus cause Post Procedural Haematoma? - 21 seconds ago
- Drug interactions of Methotrexate Sodium and Cobalamin - 22 seconds ago
- Drug interactions of Clonidine Hydrochloride and Bupropion Hydrochloride - 23 seconds ago
- Could Lantus cause Abortion Spontaneous? - 23 seconds ago